Efficacy and Safety of Once-Weekly Semaglutide Versus Once-Daily Insulin Glargine as Add-on to Metformin (With or Without Sulfonylureas) in Insulin-Naive Patients With Type 2 Diabetes (SUSTAIN 4): A Randomised, Open-Label, Parallel-Group, Multicentre, Mul
coli ), and Staphylococcus aureus ( S
6 Limitations Nevertheless, the study has limitations
JANUVIA Tablets contain sitagliptin phosphate, an orally-active inhibitor of the dipeptidyl peptidase-4 (DPP-4) enzyme
Revista Espaola de Enfermedades Digestivas, 103(6), 332
148 Limitations and perspectives PSC-based therapies While increasing cardiovascular regeneration holds promise for improving outcomes after cardiac injury, significant challenges remain before cardiovascular regeneration can be widely applied